Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? - Wikidata - awgldk - TriplyDB

Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?

Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?

http://www.wikidata.org/entity/Q35113121

about

Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α Neuropeptide Y in normal eating and in genetic and dietary-induced obesity Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?Immune heterogeneity in neuroinflammation: dendritic cells in the brain ACL deficiency impairs the vasoconstrictive efficacy of neuropeptide Y and phenylephrine in articular tissues: a laser speckle perfusion imaging study.Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.Elevated corticosterone in the dorsal hindbrain increases plasma norepinephrine and neuropeptide Y, and recruits a vasopressin response to stress Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth.Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome.Neuroimmunomodulation in human autoimmune liver disease.Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions.Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart function.Inflammation and neuropeptides: the connection in diabetic wound healing.Exercise training and peripheral arterial disease.Diabetic neuropathy and heart failure: role of neuropeptides.Reversible cerebral vasoconstriction syndrome: current and future perspectives.Adipose stem cell-based soft tissue regeneration.Receptors and ionic transporters in nuclear membranes: new targets for therapeutical pharmacological interventions.The Proline 7 Substitution in the Preproneuropeptide Y Is Associated with Higher Hepatic Lipase Activity In Vivo.Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway.Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line Expression of Neuropeptide Y, Substance P, and their receptors in the right atrium of diabetic patients.Neuropeptide Y level in paraventricular nucleus of experimental diabetic rats: correlation with sympathetic activity and body weight.Neuropeptide Y T1128C polymorphism: an independent predictor of hypertensive and cardiovascular diseases?Duck cerebellum participates in regulation of food intake via the neurotransmitters serotonin and neuropeptide Y.Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice.The correlation between SNPs within the gene of adrenergic receptor and neuropeptide Y and risk of cervical vertigo.Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats.Neuropeptide Y overflow and metabolism in skeletal muscle arterioles.The Role of Neuropeptide Y in Cardiovascular Health and Disease

P2860

Q24292941-FDFB783C-2A01-4C9E-8F52-785F8E395F81 Q24669972-5E46C78F-FE3D-4EA8-9991-F8027159F719 Q24813111-41126315-6AA2-4E02-A30B-327D113B8163 Q28385127-D183BB6A-9EB8-4A97-B292-9C06F6AFAA39 Q31109327-9C8E37F3-55A1-41F3-A121-D63B703869E5 Q33855497-BF976FAF-5449-4068-B64D-25F1CB0CCB91 Q33912973-E5B095FD-EBD0-4EBD-BCFC-43780059688F Q33917136-9E948507-1289-4EE0-9FA0-13A7646A0E22 Q34072897-878E073A-E3D7-4AC2-8638-2371368994F9 Q34506820-3ECDD427-26E6-44B0-A9B4-98917D452C42 Q34861671-8C361DAF-9088-498B-9158-5615EFE6CCD1 Q35629529-9C8437F8-3B53-400E-8D69-611C42BDF088 Q35679640-6FA4A7E5-C3EA-43A3-8FE9-10A05273F270 Q35761627-C581307D-E24A-4D59-A1B9-EF1261D6E470 Q36515510-A10538DF-CD0B-40A6-88A0-7AEB46436DC2 Q36602618-26E0A231-5BB3-4326-A65F-39B79B002D4A Q37002385-FEB6132D-5C95-4D94-B042-137C9CC60253 Q37157213-41ED75B3-BC00-4D2D-9D25-9F4D35CBB9EC Q37914972-23F60F5C-84FD-4280-9E50-B60A55BEE88A Q37921763-56B5DC42-05A7-4BC2-9BFB-307C4F36D189 Q37972387-3610761F-160B-4F2E-8CB6-AA656146C429 Q38025438-A8E3BF25-1562-47C4-A9EE-21198BF6BCA1 Q38714820-39C3F460-5AA9-4740-8B35-EA4C3FF6B6C3 Q39027921-16678243-F1DA-4A38-9796-237014226062 Q39855464-B4392890-068E-4F36-B0A1-A2DE4DCF0FC0 Q42015127-D7790465-135B-4F30-83AB-5D50885E7EA1 Q42401223-0886F404-E75D-47DD-B354-AE8527092624 Q42756242-FFCE547D-3121-421E-A271-72D491B4A0E0 Q46377545-A9D038F7-45D7-4977-86AE-F53220EC1E59 Q46947704-5E91C5F2-32FB-46F5-A680-CBB48A5EA56F Q48191872-4A76F48C-3EBE-428F-946D-D370BEA88D2C Q49583254-D53E6B01-5212-4EE5-889E-666A7CE8F29B Q51465674-2DC7A760-6EA1-428B-8546-BCE06F2C8C1E Q57073005-1DC757D3-75DD-445D-8042-8ABBB7DD1909

P2860

Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?

http://www.wikidata.org/entity/Q35113121

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Neuropeptide Y: a new mediator ...... ood vessels and immune system?

@ast

Neuropeptide Y: a new mediator ...... ood vessels and immune system?

@en

type

label

Neuropeptide Y: a new mediator ...... ood vessels and immune system?

@ast

Neuropeptide Y: a new mediator ...... ood vessels and immune system?

@en

prefLabel

Neuropeptide Y: a new mediator ...... ood vessels and immune system?

@ast

Neuropeptide Y: a new mediator ...... ood vessels and immune system?

@en

P1433

Q35113121-C70A575D-8B13-4ABD-8772-1672A8F126FA

P1476

Q35113121-ED413535-08D9-486F-95C4-B4112E29A79B

P2093

Q35113121-147F8397-053F-45BC-8BE0-288BF52EF4C9

Q35113121-390B8653-662D-413D-9090-24EA6019B799

Q35113121-6AE0D450-4D73-4DED-8426-A918B899E1D9

P2860

Q35113121-2989741B-CBCC-429D-B689-C70A5DAC35C8

Q35113121-2B1F0F5A-BB02-40D9-9039-898ADAEF9B0B

Q35113121-41B0647F-7BE0-444C-BD91-2A35CA62FBAC

Q35113121-41D57614-196E-425B-8951-C6C53A3AC1E1

Q35113121-4225A07C-06C0-40BD-8329-735E5A1C0353

Q35113121-4F747C1B-BD23-4107-833E-5E6C70FA1A25

Q35113121-59529FEA-83CF-4D58-97CD-D95C246CFDDD

Q35113121-6840765D-1120-4E16-AEDD-EA4DA30329DF

Q35113121-70900C9A-B7BC-413E-A5C2-2209E7466E62

Q35113121-738BDC6E-102F-4179-A38A-1ABD21F2D691

P304

Q35113121-569D4578-F641-4EF6-85EA-01331AC5D542

P31

Q35113121-3C4C86B5-E84D-4B65-9AC7-56DA1C98F5E0

P356

Q35113121-98C54BAC-FB69-434F-B71F-09687BDE8993

P433

Q35113121-2E2A9250-2DAF-47B7-9865-606BA52F3278

P478

Q35113121-FFB96E12-72B7-4835-88E7-FC537D34EACF

P50

Q35113121-C833331C-B0BD-4660-81F9-7D4B8F5A92D2

P577

Q35113121-A4961821-D103-4224-A530-F99AE8F7CC82

P5875

Q35113121-28AD922A-BEAF-411F-9F84-BF1E4E97798D

P698

Q35113121-C6F68737-8F4E-45AA-A386-A24DAD30E65F

P356

P1433

Canadian Journal of Physiology and Pharmacology

P1476

Neuropeptide Y: a new mediator ...... ood vessels and immune system?

@en

P2093

Edward W Lee

http://www.w3.org/2001/XMLSchema#string

Jennifer Pons

http://www.w3.org/2001/XMLSchema#string

Lijun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Cloned human neuropeptide Y receptor couples to two different second messenger systems

A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells

A receptor subtype involved in neuropeptide-Y-induced food intake

Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

Good or evil: CD26 and HIV infection.

Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension.

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.

Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation.

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

P304

89-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/Y03-006

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10790451

http://www.w3.org/2001/XMLSchema#string

P698

12710520

http://www.w3.org/2001/XMLSchema#string